Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Price from Yahoo Finance, delayed · Fundamentals as reportedData as published. No model runs on this page.
A next-day technical read — trend, RSI, ATR and volume distilled into a directional read with a calibrated range, scored against tomorrow's close. Sign in to run it.
Automated flags from the reported numbers. Context, not a call.
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 6,758 | 6,903 | 7,237 | 7,114 | 7,696 | 8,038 | 8,381 | 8,528 | 8,572 | 8,828 | 8,753 |
Generated on demand from the fundamentals above plus a live web scan. Takes one to two minutes.
The business narrative, written down and turned into explicit assumptions.
A valuation from those assumptions, under bull, base and bear cases.
Where today's price sits relative to that range.
| 7,546 |
| 8,100 |
| Expenses + | 4,696 | 4,894 | 5,214 | 5,283 | 5,566 | 5,962 | 6,108 | 6,530 | 6,398 | 6,818 | 6,866 | 7,164 | 7,240 |
| Operating Profit | 2,062 | 2,008 | 2,023 | 1,831 | 2,130 | 2,076 | 2,273 | 1,998 | 2,174 | 2,010 | 1,888 | 382 | 860 |
| OPM % | 31% | 29% | 28% | 26% | 28% | 26% | 27% | 23% | 25% | 23% | 22% | 5% | 11% |
| Other Income + | 178 | 319 | 219 | 201 | 193 | 314 | 154 | 528 | 290 | 330 | 271 | 480 | 356 |
| Interest | 37 | 35 | 39 | 59 | 60 | 76 | 82 | 66 | 83 | 91 | 94 | 106 | 126 |
| Depreciation | 353 | 376 | 374 | 368 | 381 | 397 | 471 | 455 | 476 | 505 | 521 | 557 | 537 |
| Profit before tax | 1,850 | 1,917 | 1,829 | 1,605 | 1,883 | 1,917 | 1,874 | 2,005 | 1,905 | 1,745 | 1,543 | 200 | 553 |
| Tax % | 24% | 23% | 24% | 18% | 26% | 30% | 25% | 21% | 26% | 23% | 23% | -11% | 21% |
| Net Profit + | 1,405 | 1,482 | 1,381 | 1,310 | 1,392 | 1,342 | 1,404 | 1,587 | 1,410 | 1,337 | 1,190 | 221 | 436 |
| EPS in Rs | 16.87 | 17.77 | 16.56 | 15.70 | 16.69 | 15.05 | 16.94 | 19.09 | 16.99 | 16.14 | 14.50 | 2.65 | 5.32 |
| Raw PDF |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 15,023 | 15,568 | 14,196 | 14,281 | 15,448 | 17,517 | 19,048 | 21,545 | 24,670 | 28,011 | 32,644 | 33,700 | 33,228 |
| Expenses + | 11,515 | 11,983 | 11,724 | 11,930 | 12,270 | 15,040 | 15,173 | 17,778 | 18,200 | 20,078 | 24,097 | 27,247 | 28,088 |
| Operating Profit | 3,508 | 3,585 | 2,472 | 2,351 | 3,178 | 2,477 | 3,874 | 3,768 | 6,470 | 7,933 | 8,547 | 6,454 | 5,140 |
| OPM % | 23% | 23% | 17% | 16% | 21% | 14% | 20% | 17% | 26% | 28% | 26% | 19% | 15% |
| Other Income + | 260 | 295 | 172 | 155 | 381 | 670 | 335 | 555 | 971 | 909 | 1,119 | 1,372 | 1,437 |
| Interest | 108 | 83 | 63 | 79 | 89 | 98 | 97 | 96 | 143 | 171 | 283 | 374 | 416 |
| Depreciation | 760 | 939 | 1,027 | 1,077 | 1,135 | 1,163 | 1,229 | 1,165 | 1,250 | 1,470 | 1,704 | 2,059 | 2,119 |
| Profit before tax | 2,900 | 2,859 | 1,554 | 1,350 | 2,336 | 1,886 | 2,884 | 3,061 | 6,048 | 7,201 | 7,680 | 5,393 | 4,041 |
| Tax % | 19% | 26% | 19% | 32% | 17% | -7% | 32% | 29% | 25% | 23% | 25% | 23% | |
| Net Profit + | 2,336 | 2,131 | 1,292 | 947 | 1,950 | 2,026 | 1,952 | 2,182 | 4,507 | 5,578 | 5,725 | 4,158 | 3,183 |
| EPS in Rs | 27.43 | 24.98 | 15.59 | 11.41 | 23.49 | 24.38 | 23.47 | 26.23 | 54.14 | 66.87 | 67.77 | 50.27 | 38.61 |
| Dividend Payout % | 15% | 16% | 26% | 35% | 17% | 21% | 21% | 23% | 15% | 12% | 12% | 16% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 85 | 85 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 84 |
| Reserves | 9,768 |
| 12,484 |
| 12,179 |
| 12,489 |
| 13,941 |
| 15,516 |
| 17,558 |
| 19,129 |
| 23,203 |
| 28,171 |
| 33,466 |
| 37,808 |
| Borrowings + | 4,314 | 3,352 | 4,918 | 5,071 | 3,838 | 2,210 | 3,031 | 3,384 | 1,347 | 2,002 | 4,677 | 7,734 |
| Other Liabilities + | 4,290 | 4,408 | 4,474 | 4,706 | 4,557 | 5,414 | 5,915 | 7,149 | 7,576 | 8,523 | 9,797 | 10,951 |
| Total Liabilities | 18,457 | 20,330 | 21,654 | 22,349 | 22,418 | 23,223 | 26,588 | 29,746 | 32,209 | 38,780 | 48,023 | 56,577 |
| Fixed Assets + | 5,377 | 6,563 | 6,931 | 6,968 | 7,191 | 6,850 | 8,206 | 8,122 | 9,219 | 10,426 | 18,226 | 22,063 |
| CWIP | 529 | 772 | 3,324 | 3,470 | 2,934 | 1,535 | 1,565 | 1,293 | 1,030 | 1,419 | 2,466 | 1,460 |
| Investments | 2,248 | 3,833 | 2,110 | 2,298 | 2,587 | 2,678 | 2,212 | 2,616 | 4,986 | 4,930 | 4,051 | 5,285 |
| Other Assets + | 10,303 | 9,162 | 9,290 | 9,612 | 9,707 | 12,160 | 14,605 | 17,715 | 16,974 | 22,004 | 23,280 | 27,768 |
| Total Assets | 18,457 | 20,330 | 21,654 | 22,349 | 22,418 | 23,223 | 26,588 | 29,746 | 32,209 | 38,780 | 48,023 | 56,577 |